Immunology drugs
76 results
Advair hfa (fluticasone propionate and salmeterol xinafoate)
(fluticasone propionate and salmeterol xinafoate)GlaxoSmithKline LLC
Usage: ADVAIR HFA is indicated for treating asthma in adults and adolescents (12 years and older) not adequately controlled on long-term asthma medications, specifically when a combination of an inhaled corticosteroid and a long-acting beta2-adrenergic agonist is necessary. It is not for acute bronchospasm relief.
Afstyla (antihemophilic factor, human recombinant)
(ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT)CSL Behring Lengnau AG
Usage: AFSTYLA is indicated for adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, routine prophylaxis to reduce bleeding frequency, and perioperative management of bleeding. It is not indicated for von Willebrand disease.
Alvesco (ciclesonide)
(ciclesonide)Covis Pharma US, Inc
Usage: ALVESCO is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older. It is not meant for acute bronchospasm relief and is not approved for use in children under 12.
Alyftrek (vanzacaftor, tezacaftor, and deutivacaftor)
(vanzacaftor, tezacaftor, and deutivacaftor)Vertex Pharmaceuticals Incorporated
Usage: ALYFTREK is indicated for treating cystic fibrosis in patients aged 6 and older with at least one F508del mutation or another responsive CFTR mutation. An FDA-cleared CF mutation test is recommended if the patient's genotype is unknown.
Apretude (cabotegravir)
(Cabotegravir)ViiV Healthcare Company
Usage: APRETUDE is indicated for pre-exposure prophylaxis (PrEP) to decrease the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk. A negative HIV-1 test is required before starting APRETUDE.
Arcalyst (rilonacept)
(rilonacept)Kiniksa Pharmaceuticals (UK), Ltd.
Usage: ARCALYST (rilonacept) is indicated for treating Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) in patients 12 years and older; maintenance of remission in Deficiency of IL-1 Receptor Antagonist (DIRA); and recurrent pericarditis in patients 12 years and older.
Arnuity ellipta (fluticasone furoate)
(fluticasone furoate)GlaxoSmithKline LLC
Usage: ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adults and pediatric patients aged 5 years and older. It is not intended for the relief of acute bronchospasm.
Asceniv (human immunoglobulin g)
(HUMAN IMMUNOGLOBULIN G)ADMA Biologics, Inc.
Usage: ASCENIV is indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents aged 12 to 17. This includes conditions such as congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).
Berinert (human c1-esterase inhibitor)
(HUMAN C1-ESTERASE INHIBITOR)CSL Behring GmbH
Usage: BERINERT is indicated for the treatment of acute abdominal, facial, or laryngeal hereditary angioedema (HAE) attacks in both adult and pediatric patients. Its safety and efficacy for prophylactic therapy have not been established.
Bivigam (immune globulin intravenous (human) 10%)
(Immune Globulin Intravenous (Human) 10%)ADMA Biologics, Inc.
Usage: BIVIGAM is indicated for treating primary humoral immunodeficiency in adults and children aged 2 years and older, including conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
- ...